DYMAX Europe GmbH is taking part in the premiere of the MedTec in Italy

Product presentation of the new SD-100 syringe dispenser

Wiesbaden, (PresseBox) - DYMAX Europe GmbH is participating at the first MedTec show in Italy September 26.- 27, 2012 in Modena. With the expansion of the trade show series, DYMAX Europe GmbH takes the opportunity to be closer to manufacturers of medical devises locally.

DYMAX Europe GmbH is going to present not only its new digital syringe dispenser SD-100, but also a new multipurpose medical grade adhesive for plastics and metals: the Ultra-Red™ Fluorescing 1193M-SV05-UR. DYMAX Ultra-Red™ 1193M-SV05-UR is a moisture resistant, multipurpose medical device adhesive which cures upon exposure to UV and/or visible light. 1193M-SV05-UR is designed for rapid dispense and bonding of plastics and metals typically used in the manufacture of syringes and needles. This product fluoresces bright red under low-intensity "black" light (365 nm). The bright red fluorescence contrasts extremely well on plastics that naturally fluoresce blue in color (like PVC), and greatly assists with visual inspection of the bond-line area.

The new products of DYMAX will be presented at:

MedTec Italy, Modena, Hall: B, Stand: 1320

DYMAX Europe GmbH

For additional information, visit www.dymax.com or contact +49 (0)611 962 7900. Dymax Corporation develops innovative oligomer, adhesive, coating, dispensing, and light-curing systems for applications in a wide range of markets. Major markets include aerospace, appliance, automotive, electronics, industrial, medical device, and metal finishing.

Diese Pressemitteilungen könnten Sie auch interessieren

News abonnieren

Mit dem Aboservice der PresseBox, erhalten Sie tagesaktuell und zu einer gewünschten Zeit, relevante Presseinformationen aus Themengebieten, die für Sie interessant sind. Für die Zusendung der gewünschten Pressemeldungen, geben Sie bitte Ihre E-Mail-Adresse ein.

Es ist ein Fehler aufgetreten!

Vielen Dank! Sie erhalten in Kürze eine Bestätigungsemail.


Ich möchte die kostenlose Pressemail abonnieren und habe die Bedingungen hierzu gelesen und akzeptiert.